Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist.

BORIS DOI
Publisher DOI
PubMed ID
32816740
Description
Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision making process in evidence based medicine. Although such studies are regarded as high level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalisability, and subsequently their value to key stakeholders. An extension of the PRISMA (preferred reporting items for systematic review and meta-analysis) statement was recently developed to improve the reporting quality of DTA systematic reviews. The PRISMA-DTA statement has 27 items, of which eight are unmodified from the original PRISMA statement. This article provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices.
Date of Publication
2020-08-14
Publication Type
article
Subject(s)
600 - Technology::610 - Medicine & health
300 - Social sciences, sociology & anthropology::360 - Social problems & social services
Language(s)
en
Contributor(s)
Salameh, Jean-Paul
Bossuyt, Patrick M
McGrath, Trevor A
Thombs, Brett D
Hyde, Christopher J
Macaskill, Petra
Deeks, Jonathan J
Leeflang, Mariska
Korevaar, Daniël A
Whiting, Penny
Takwoingi, Yemisi
Reitsma, Johannes B
Cohen, Jérémie F
Frank, Robert A
Hunt, Harriet A
Hooft, Lotty
Willis, Brian H
Gatsonis, Constantine
Levis, Brooke
Moher, David
McInnes, Matthew D F
Additional Credits
Berner Institut für Hausarztmedizin (BIHAM)
Series
BMJ
Publisher
BMJ Publishing Group
ISSN
1756-1833
Access(Rights)
open.access
Show full item